Search for: "PFIZER" Results 2681 - 2700 of 4,635
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 May 2011, 5:36 am
"Pfizer Sets Aside $772 Million, Settles One-Third of Prempro Drug Cases": Jef Feeley of Bloomberg News has this report. [read post]
12 May 2011, 12:00 pm by Paul Caron
Accounting Today, Congressional Bill Provides Tax Holiday on Corporate Profits Repatriation Bloomberg, Chief Financial Officers Oppose One-Time Repatriation Holiday Bloomberg, Lawmakers Propose One-Year Holiday on Repatriating Profits Bloomberg, Tax Holiday Sought by Pfizer, Google Would Cost $78.7 Billion Financial Times, US Tax Holiday Proposed for Foreign Profits The Hill, Bipartisan... [read post]
11 May 2011, 9:06 am by utahpi
Pfizer’s first-quart report included a charge of $472 million primarily to cover settlements and potential future liabilities in the long-running product liability litigation surrounding Pfizer’s hormone-replacement therapies including Prempro. [read post]
11 May 2011, 4:54 am by Marie Louise
State Patent Bureau of the Republic of Lithuania (Kluwer Patent Blog) Spain: Modification of EP translations (2) – Supreme Court grants fourth appeal, filed again by Pfizer: EP0325571 (PatLit) US: Federal Trade Commission issues report on reverse settlement agreements in FY2010 (Patent Docs) (Orange Book Blog) (FDA Law Blog) US: FTC posts friendly reminder to please send them your ANDA litigation settlement agreements (Orange Book Blog) US: Billups-Rothenberg v. [read post]
10 May 2011, 11:59 pm
Last week, Wyeth (a subsidiary of Pfizer) reached a settlement with Indian drug makers, Dr. [read post]
10 May 2011, 2:08 pm by Above the Law
We also continue to add great speakers to the panels, including Nishan DeSilva of Microsoft, Ronke Ekwensi of Pfizer, Paul Meyer of Towers Watson, and Demetrius Rush of Zurich N.A.Space is limited, so please sign up now to attend.Legal Technology Leadership SummitEarlier: For Legal Technology, Above the Law Needs An Entire Summit [read post]
10 May 2011, 11:43 am by Robert Thomas (inversecondemnation.com)
The Court might have had a different view if, say, the city condemned the property specifically in order to turn it over to Pfizer (rather than to turn it over to a developer, who later turned out to be Pfizer). [read post]
9 May 2011, 11:38 am by Ted Allen
Pfizer and J&J both received more than 39 percent dissent, nearly four times the average opposition rate this year. [read post]
9 May 2011, 8:18 am by Kara OBrien
Several notable companies that obtained majority support for say-on-pay nonetheless faced significant opposition, most recently Johnson & Johnson (61.2%) and Pfizer (57.6%), which were also the subject of active campaigns by AFSCME. [read post]
6 May 2011, 11:02 am by Rebecca Tushnet
Pfizer is now talking about its open innovation practices. [read post]
4 May 2011, 8:32 am by Mary Todd
To counter these arguments, proponents of the whistleblower program cite to other successful programs with robust monetary rewards like that under the False Claims Act, which helped facilitate large settlements with pharmaceutical giants Pfizer and Eli Lilly for corporate misconduct. [read post]
3 May 2011, 10:36 pm
Recently, however, Pfizer has been subjected to various lawsuits over the side effects of Effexor. [read post]
3 May 2011, 7:16 am by Zoe Tillman
Pfizer has held exclusive rights to Lipitor for 15 years, according to Boasberg’s opinion. [read post]
2 May 2011, 8:08 pm by Aaron Barkoff
" Under the terms of a settlement with Pfizer, Ranbaxy will launch its generic Lipitor on November 30, 2011 (provided that its ANDA has been approved by then). [read post]
2 May 2011, 4:25 am by Broc Romanek
Ted Allen's blog provides some analysis, including noting significant levels of "no" votes at Pfizer and Johnson & Johnson (both of whom are S&P 500 companies). [read post]
29 Apr 2011, 11:57 pm by Apeng
(Reexamination Alert) (Orange Book Blog) (Patently-O) (America-Israel Patent Law) (Patents Post-Grant) (IPBiz) (Patent Law Practice Center) Pfizer starts R&D in China after IPR in China challenges / ?????????????????????????? [read post]